Patel Shriji N, Kim Stephen J, Lalezary Maziar, Shah Rohan, Kuchtey Rachel W, Joos Karen M, Kammer Jeffrey A, Cherney Edward F
Ophthalmic Surg Lasers Imaging Retina. 2019 Jun 1;50(6):371-376. doi: 10.3928/23258160-20190605-05.
This paper reports 3-year intraocular pressure (IOP) outcomes of the Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) study.
The prospective, controlled, observational study included 80 eyes of 40 participants undergoing routine pars plana vitrectomy. Study patients underwent preoperative evaluation and multimodal testing of the study (surgical) and fellow (control) eye. This testing was repeated at 3 months postoperatively and then annually for 3 years.
Thirty-two of 40 patients (80%) completed 3-year follow-up. At 3 years postoperatively, there was no difference in IOP measurements in surgical eyes overall from baseline (P = .36). Subgroup analysis of pseudophakic eyes at baseline showed a significant elevation in IOP from 14.3 mm Hg ± 2.9 mm Hg at baseline to 16.8 mm Hg ± 3.2 mm Hg at 3-year follow-up (P < .029). Fellow eyes did not experience a significant change from baseline.
The authors' 3-year results show that IOP is consistently and significantly elevated in pseudophakic eyes compared to baseline following routine vitrectomy. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:371-376.].
本文报告了视网膜和视神经玻璃体切除术前瞻性评估(PROVE)研究的3年眼压(IOP)结果。
这项前瞻性、对照、观察性研究纳入了40名接受常规扁平部玻璃体切除术患者的80只眼睛。研究患者对研究眼(手术眼)和对侧眼(对照眼)进行了术前评估和多模式检测。术后3个月重复此项检测,随后3年每年进行一次。
40名患者中有32名(80%)完成了3年随访。术后3年,手术眼的眼压测量值与基线相比总体无差异(P = 0.36)。基线时人工晶状体眼的亚组分析显示,眼压从基线时的14.3 mmHg±2.9 mmHg显著升高至3年随访时的16.8 mmHg±3.2 mmHg(P < 0.029)。对侧眼与基线相比无显著变化。
作者的3年研究结果表明,与常规玻璃体切除术后的基线相比,人工晶状体眼的眼压持续且显著升高。[《眼科手术、激光与视网膜成像》。2019;50:371 - 376。]